The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases.
about
The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The efficacy, safety, and feas ...... s mycobacterial lung diseases.
@en
type
label
The efficacy, safety, and feas ...... s mycobacterial lung diseases.
@en
prefLabel
The efficacy, safety, and feas ...... s mycobacterial lung diseases.
@en
P2093
P2860
P50
P1476
The efficacy, safety, and feas ...... s mycobacterial lung diseases.
@en
P2093
Hiroaki Sugiura
Hiroshi Fujiwara
Ho Namkoong
Kazuma Yagi
Naoki Hasegawa
Osamu Iketani
Sadatomo Tasaka
Shoji Suzuki
Takahiro Asami
Tetsuro Kamo
P2860
P2888
P356
10.1186/S12879-017-2665-5
P577
2017-08-09T00:00:00Z
P6179
1091133319